Graftac 0,5 Prolonged Release


Capsules
scheduling status
S4
registration number
55/34/0854
What Graftac 0,5 Prolonged Release contains
Each capsule contains 0,500 mg of tacrolimus equivalent to 0,511 mg of tacrolimus monohydrate.
other ingredients
Capsule content: Ethylcellulose, hypromellose type 2910, lactose monohydrate, magnesium stearate Body Composition: Sunset yellow FCF (E110), allura red AC (E129), brilliant blue FCF (E133), titanium dioxide (E171), gelatine Cap Composition: Tartrazine (E102), titanium dioxide (E171), gelatine.
Therapeutic classification
A.34 Other (Immuno-suppressive macrolide lactone).
© 2026 SAHPRA. ALL RIGHTS RESERVED